Cite

HARVARD Citation

    Llombart, A. et al. (n.d.). 28PImpact of the 21-gene assay on treatment decisions in high-risk patients with ER-positive HER2-negative early breast cancer: Results of the KARMA Dx study. Annals of oncology. p. . [Online]. 
  
Back to record